Samsung Biologics memilih platform Growth Direct® oleh Rapid Micro Biosystems untuk mengautomasikan ujian kawalan kualiti mikrobiologi kritikal
January 04, 2024 09:18 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) ("Syarikat"), sebuah syarikat teknologi sains hayat inovatif yang menyediakan penyelesaian automasi...
Samsung Biologics, 주요 미생물 품질 관리 테스트 공정 자동화를 위해 Rapid Micro Biosystems의 Growth Direct® 플랫폼 채택
January 04, 2024 09:18 ET
|
Rapid Micro Biosystems, Inc.
매사추세츠주 로웰, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- 회사가 핵심과제로 삼은 자동화 솔루션을 통해 헬스케어 제품의 효율적인 제조와 신속하고 안전한 출시를 지원하는 혁신적인 생명과학 기술 기업인 Rapid Micro Biosystems, Inc. (래피드 마이크로 바이오시스템즈) (나스닥: RPID) (이하...
サムスンバイオロジクス （Samsung Biologics）、重要な微生物の品質管理テスト自動化にラピッド・マイクロ・バイオシステムズ (Rapid Micro Biosystems) のグロースダイレクト (Growth Direct®) プラットフォームを選択
January 04, 2024 09:18 ET
|
Rapid Micro Biosystems, Inc.
マサチューセッツ州ローウェル発, Jan. 04, 2024 (GLOBE NEWSWIRE) -- ヘルスケア製品の効率的な製造と迅速かつ安全なリリースを促進するミッションクリティカルな自動化ソリューションを提供する革新的なライフサイエンステクノロジー企業であるラピッド・マイクロ・バイオシステムズ (Rapid Micro Biosystems, Inc.) (NASDAQ: RPID)...
Samsung Biologics selects Rapid Micro Biosystems’ Growth Direct® platform to automate critical microbiology quality control testing
January 04, 2024 07:00 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024 07:15 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
November 07, 2023 16:15 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Third Quarter 2023 Financial Results
November 03, 2023 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports third quarter 2023 total revenue of $6.1 million, representing growth of 30% compared to third quarter 2022 Reaffirms full year 2023 total revenue guidance of at least $22.0 million,...
Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023
October 19, 2023 16:15 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation...
Rapid Micro Biosystems to Exhibit at the 2023 PDA Pharmaceutical Microbiology Conference from October 2 – 4
September 29, 2023 09:25 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Participate in the Virtual Gilmartin Group Emerging Growth Company Showcase
September 19, 2023 17:15 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...